American Journal of Psychiatry Journal

Overview
Identity
View All

publication venue for

Differences in Brain Glucose Metabolism Between Responders to CBT and Venlafaxine in a 16-Week Randomized Controlled Trial 2007
Self-Help for Bulimia Nervosa: A Randomized Controlled Trial 2003
Meta-Analyses of Genome-Wide Association Studies for Postpartum Depression. 180:884-895. 2023
Subcortical Brain Volume, Regional Cortical Thickness, and Cortical Surface Area Across Disorders: Findings From the ENIGMA ADHD, ASD, and OCD Working Groups. 177:834-843. 2020
No Alterations of Brain Structural Asymmetry in Major Depressive Disorder: An ENIGMA Consortium Analysis. 176:1039-1049. 2019
Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled Trial. 176:401-409. 2019
Cortical Abnormalities Associated With Pediatric and Adult Obsessive-Compulsive Disorder: Findings From the ENIGMA Obsessive-Compulsive Disorder Working Group. 175:453-462. 2018
Reduction of PTSD Symptoms With Pre-Reactivation Propranolol Therapy: A Randomized Controlled Trial. 175:427-433. 2018
Distinct Subcortical Volume Alterations in Pediatric and Adult OCD: A Worldwide Meta-and Mega-Analysis (vol , pg , 2016). 174:190-190. 2017
Distinct Subcortical Volume Alterations in Pediatric and Adult OCD: A Worldwide Meta- and Mega-Analysis. 174:60-69. 2017
A Diffusion Tensor Imaging Study in Children With ADHD, Autism Spectrum Disorder, OCD, and Matched Controls: Distinct and Non-Distinct White Matter Disruption and Dimensional Brain-Behavior Relationships. 173:1213-1222. 2016
A Diffusion Tensor Imaging Study in Children With ADHD, Autism Spectrum Disorder, OCD, and Matched Controls: Distinct and Non-Distinct White Matter Disruption and Dimensional Brain-Behavior Relationships. 173:1213-1222. 2016
Response to Silberman. 171:795-796. 2014
A Double-Blind Randomized Controlled Trial of Augmentation and Switch Strategies for Refractory Social Anxiety Disorder. 171:44-53. 2014
The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders. 170:1249-1262. 2013
Neurodevelopment of Children Following Prenatal Exposure to Venlafaxine, Selective Serotonin Reuptake Inhibitors, or Untreated Maternal Depression. 169:1165-1174. 2012
Prenatal Exposure to Antidepressants: How Safe Are They?. 169:1130-1132. 2012
Dialectical Behavior Therapy Compared With General Psychiatric Management for Borderline Personality Disorder: Clinical Outcomes and Functioning Over a 2-Year Follow-Up. 169:650-661. 2012
Premenstrual Dysphoric Disorder: Evidence for a New Category for DSM-5. 169:465-475. 2012
Response to Mahendran Letter. 169:433-434. 2012
Introducing Psychiatry to Rural Physicians in China: An Innovative Education Project. 168:1249-1254. 2011
Antidepressant Use in Bipolar Disorder: Continuing an Age-Old Debate. 167:1408-1408. 2010
Limitations of the Hamilton Anxiety Rating Scale as a Primary Outcome Measure in Randomized, Controlled Trials of Treatments for Generalized Anxiety Disorder. 167:103-104. 2010
A Randomized Trial of Dialectical Behavior Therapy Versus General Psychiatric Management for Borderline Personality Disorder. 166:1365-1374. 2009
Genomewide Association Studies: History, Rationale, and Prospects for Psychiatric Disorders. 166:540-556. 2009
Can Traumatized Children Report Revenge Fantasies?. 164:975-976. 2007
Can Traumatized Children Report Revenge Fantasies?. 164:975-976. 2007
Differences in Brain Glucose Metabolism Between Responders to CBT and Venlafaxine in a 16-Week Randomized Controlled Trial. 164:778-788. 2007
Elevated Putamen D ₂ Receptor Binding Potential in Major Depression With Motor Retardation: An [ ¹¹ C]Raclopride Positron Emission Tomography Study. 163:1594-1602. 2006
Elevated Putamen D<char aid="99821877" id="sub">2</char> Receptor Binding Potential in Major Depression With Motor Retardation: An [<char aid="99821878" id="sup">11</char>C]Raclopride Positron Emission Tomography Study. 163:1594-1594. 2006
Practical Management of Personality Disorder. 162:1559-1559. 2005
Specialized Inpatient Trauma Treatment for Adults Abused as Children: A Follow-Up Study. 162:552-559. 2005
Cholesterol Metabolism and Suicidality in Smith-Lemli-Opitz Syndrome Carriers. 161:2123-2126. 2004
Childhood Abuse and Suicidality in Women. 161:762-763. 2004
Enhanced Salience and Emotion Recognition in Autism: A PET Study. 160:1439-1441. 2003
The Relationship Between Childhood Physical Abuse and Suicidality Among Depressed Women: Results From a Community Sample. 160:933-938. 2003
Affective Instability in Personality Disorders. 160:394-395. 2003
Real-Life Research. 160:387-387. 2003
Dysfunctional Attitudes and 5-HT₂ Receptors During Depression and Self-Harm. 160:90-99. 2003
The suicidal patient: Clinical and legal standards of care, 2nd edition. 159:1445-1446. 2002
Self-Injurious Behaviors: Assessment and Treatment. 159:692-692. 2002
Childhood Abuse and Lifetime Psychopathology in a Community Sample. 158:1878-1883. 2001
Antidepressant use among elderly patients.. 158:328-330. 2001
Dr. Mamdani and Colleagues Reply. 158:329-330. 2001
Sertraline Treatment of Generalized Social Phobia: A 20-Week, Double-Blind, Placebo-Controlled Study. 158:275-281. 2001
Childhood Abuse and Psychiatric Disorders Among Single and Married Mothers. 158:73-77. 2001
The Effect of Paroxetine on 5-HT_2A Receptors in Depression: An [¹⁸F]Setoperone PET Imaging Study. 158:78-85. 2001
Two-Year Outcome of Preschool Children With Autism or Asperger’s Syndrome. 157:1980-1987. 2000
Differentiation of Homicidal Child Molesters, Nonhomicidal Child Molesters, and Nonoffenders by Phallometry. 157:1847-1850. 2000
Use of Antidepressants Among Elderly Subjects: Trends and Contributing Factors. 157:360-367. 2000
Magnetic Resonance Imaging Abnormalities and Psychiatric Illness. 157:306-307. 2000
Prefrontal Cortex 5-HT₂ Receptors in Depression: An [¹⁸F]Setoperone PET Imaging Study. 156:1029-1034. 1999
Serotonin 5-HT₂ Receptors in Schizophrenia: A PET Study Using [¹⁸F]Setoperone in Neuroleptic-Naive Patients and Normal Subjects. 156:72-78. 1999
No Effect of Depression on [¹⁵O]H₂O PET Response to Intravenous d-Fenfluramine. 155:1241-1246. 1998
Clinical and Methodological Factors Related to Reliability of the Best-Estimate Diagnostic Procedure. 154:1726-1733. 1997
Response to hyperventilation and 5.5% CO2 inhalation of subjects with types of specific phobia, panic disorder, or no mental disorder. 154:1089-1095. 1997
Major theories of personality disorder - Clarkin,JF, Lenzenweger,MF. 154:704-705. 1997
Protracted akathisia after risperidone withdrawal. 154:437b-438. 1997
Circadian pattern of acute, neuroleptic-induced dystonic reactions. 153:708-710. 1996
Multicenter, placebo-controlled study of fluoxetine in seasonal affective disorder. 152:1765-1770. 1995
Field trial for autistic disorder in DSM-IV. 151:1361-1367. 1994
Familial aggregation of emotional and behavioral problems of childhood in the general population. 150:1398-1403. 1993
Auditory hallucinations in schizophrenic patients. 150:1275b-1276. 1993
Dr. Szechtman and Colleagues Reply. 150:1276-1276. 1993
Do benzodiazepines modify the incidence of neuroleptic-induced dystonia?. 150:528-529. 1993
The Treatment of Catatonia: Benzodiazepines or ECT?. 149:1279-1279. 1992
Toward a brain map of auditory hallucinations. 149:1062-1069. 1992
Predicting substance use in late adolescence: results from the Ontario Child Health Study follow-up. 149:761-767. 1992
Algorithms versus decision trees in DSM-III-R. 148:1609c-1610. 1991
LOW SERUM IRON LEVELS AND NEUROLEPTIC MALIGNANT SYNDROME - REPLY. 148:148-149. 1991
Reliability of a Standardized Mini-Mental State Examination compared with the traditional Mini-Mental State Examination. 148:102-105. 1991
A prospective analysis of 24 episodes of neuroleptic malignant syndrome. 146:717-725. 1989
Imipramine and clonazepam for panic disorder.. 146:283-284. 1989
Ontario Child Health Study: suicidal behavior in youth age 12-16 years. 145:1420-1423. 1988
Drugs and the DST: need for a reappraisal. 145:666-674. 1988
Hypothalamic pathology in the neuroleptic malignant syndrome. 145:617-620. 1988
Double-blind, placebo-controlled studies of bulimic patients.. 143:1197-1198. 1986
Stability of the diagnostic interview for borderlines diagnosis.. 142:1525. 1985
Response of borderline and schizotypal patients to small doses of thiothixene and haloperidol. 141:1455-1458. 1984
Type II error in diagnosing borderline patients. 140:960a-960. 1983
Triiodothyronine, imipramine, and depression. 137:383b-384. 1980
Sexual function and affect in parkinsonian men treated with L-dopa. 135:1552-1555. 1978
Effect of haloperidol and apomorphine treatment on dopamine receptors in pituitary and striatum. 135:839-841. 1978
Selection criteria for dialysis and renal transplant. 135:861-863. 1978
Psychoneuroendocrinology of affective disorder: an overview. 134:493-501. 1977
CRIMINALITY AND PSYCHIATRIC-DISORDERS - GUZE,SB. 134:1166-1167. 1977
DRUG INTERACTIONS - CLINICAL SIGNIFICANCE OF DRUG-DRUG INTERACTIONS AND DRUG EFFECTS ON CLINICAL LABORATORY RESULTS - HANSTEN,PD. 134:1319-1320. 1977
Thyrotropin-releasing hormone: differential antidepressant and endocrinological effects. 133:1187-1190. 1976
Letter: The Capgras syndrome in a male. 132:297a-297. 1975
PHENOTHIAZINES, SKIN PIGMENTATION AND RELATED EYE FINDINGS. 122:326-327. 1965
ELECTROSHOCK AND THIORIDAZINE THERAPY IN THE PRESENCE OF GLAUCOMA. 120:397-398. 1963
CORONARY OCCLUSION DURING EST. 120:78-79. 1963
CLINICAL-STATISTICAL ANALYSIS OF POPULATION CHANGES IN NEW YORK STATE MENTAL HOSPITALS SINCE INTRODUCTION OF PSYCHOTROPIC DRUGS. 119:20-35. 1962
In memoriam: Harry J. Worthing; 1888-1958.. 115:767-768. 1959
ANALYSIS OF 1955-1956 POPULATION FALL IN NEW YORK STATE MENTAL HOSPITALS IN FIRST YEAR OF LARGE-SCALE USE OF TRANQUILIZING DRUGS. 114:509-517. 1957
EVALUATION OF IMMEDIATE AND LATE RESULTS OF PREFRONTAL LOBOTOMY IN 600 CASES, INCLUDING A CASE OF POST-ENCEPHALITIS AND OTHER ORGANIC STATES. 108:328-336. 1951

has subject area

11 Medical and Health Sciences (FoR)
17 Psychology and Cognitive Sciences (FoR)
Psychiatry (Science Metrix)